Capital World Investors Buys 100,000 Shares of Ralliant Corporation $RAL

Capital World Investors increased its stake in Ralliant Corporation (NYSE:RAL) by 6.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,652,364 shares of the company’s stock after purchasing an additional 100,000 shares during the period. Capital World Investors owned approximately 1.46% of Ralliant worth $84,122,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Danske Bank A S bought a new position in shares of Ralliant in the fourth quarter worth approximately $25,000. Allworth Financial LP increased its position in shares of Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after purchasing an additional 293 shares during the last quarter. V Square Quantitative Management LLC bought a new position in shares of Ralliant in the fourth quarter worth approximately $26,000. Palisade Asset Management LLC bought a new position in shares of Ralliant in the third quarter worth approximately $26,000. Finally, Rothschild Investment LLC increased its position in shares of Ralliant by 98.1% in the fourth quarter. Rothschild Investment LLC now owns 612 shares of the company’s stock worth $31,000 after purchasing an additional 303 shares during the last quarter.

Ralliant Stock Up 4.3%

Shares of Ralliant stock opened at $63.66 on Wednesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61. Ralliant Corporation has a 52-week low of $37.27 and a 52-week high of $64.16. The stock has a market capitalization of $7.13 billion and a price-to-earnings ratio of -5.82. The company’s 50 day moving average price is $51.63 and its 200-day moving average price is $49.45.

Ralliant (NYSE:RAL) last issued its earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.08. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. The firm had revenue of $534.60 million for the quarter. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. Equities research analysts forecast that Ralliant Corporation will post 2.64 EPS for the current year.

Ralliant Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th will be issued a $0.05 dividend. The ex-dividend date is Monday, June 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is currently -1.83%.

Analyst Ratings Changes

RAL has been the topic of several research analyst reports. Oppenheimer upped their price objective on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Wall Street Zen cut shares of Ralliant from a “buy” rating to a “hold” rating in a research report on Sunday, May 31st. Evercore assumed coverage on shares of Ralliant in a research report on Tuesday. They issued an “outperform” rating and a $80.00 price objective on the stock. Citigroup lifted their price target on shares of Ralliant from $51.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Finally, Vertical Research downgraded shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research note on Wednesday, May 27th. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $67.30.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.